Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma
Maria Teresa Landi,1*
Jürgen Bauer,2,3*
Ruth M. Pfeiffer,1
David E. Elder,4
Benjamin Hulley,1
Paola Minghetti,5
Donato Calista,5
Peter A. Kanetsky,7
Daniel Pinkel,6
Boris C. Bastian2
Abstract:
Germline variants in MC1R, the gene encoding the melanocortin-1receptor, and sun exposure increase risk for melanoma in Caucasians.The majority of melanomas that occur on skin with little evidenceof chronic sun-induced damage (non-CSD melanoma) have mutationsin the BRAF oncogene, whereas in melanomas on skin with markedCSD (CSD melanoma) these mutations are less frequent. In twoindependent Caucasian populations, we show that MC1R variantsare strongly associated with BRAF mutations in non-CSD melanomas.In this tumor subtype, the risk for melanoma associated withMC1R is due to an increase in risk of developing melanomas withBRAF mutations.
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA. 2 Departments of Dermatology and Pathology and Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. 3 Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany. 4 Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. 5 Department of Dermatology, M. Bufalini Hospital, Cesena, 47023, Italy. 6 Department of Laboratory Medicine, University of California, San Francisco, CA 94143, USA. 7 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: landim{at}mail.nih.gov
The editors suggest the following Related Resources on Science sites:
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma.
A. M. Menzies, L. E. Haydu, L. Visintin, M. S. Carlino, J. R. Howle, J. F. Thompson, R. F. Kefford, R. A. Scolyer, and G. V. Long (2012)
Clin. Cancer Res.
18, 3242-3249
|Abstract »|Full Text »|PDF »
Molecular Characterization of Human Cutaneous Melanoma-derived Cell Lines.
Z. OGBAH, J. A. PUIG-BUTILLE, F. SIMONETTA, C. BADENAS, R. CERVERA, J. MILA, D. BENITEZ, J. MALVEHY, R. VILELLA, and S. PUIG (2012)
Anticancer Res
32, 1245-1251
|Abstract »|Full Text »|PDF »
PTEN Positively Regulates UVB-Induced DNA Damage Repair.
M. Ming, L. Feng, C. R. Shea, K. Soltani, B. Zhao, W. Han, R. C. Smart, C. S. Trempus, and Y.-Y. He (2011)
Cancer Res.
71, 5287-5295
|Abstract »|Full Text »|PDF »
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma.
G. V. Long, A. M. Menzies, A. M. Nagrial, L. E. Haydu, A. L. Hamilton, G. J. Mann, T. M. Hughes, J. F. Thompson, R. A. Scolyer, and R. F. Kefford (2011)
J. Clin. Oncol.
29, 1239-1246
|Abstract »|Full Text »|PDF »
Functional EGFR Germline Polymorphisms May Confer Risk for EGFR Somatic Mutations in Non-Small Cell Lung Cancer, with a Predominant Effect on Exon 19 Microdeletions.
W. Liu, L. He, J. Ramirez, S. Krishnaswamy, R. Kanteti, Y.-C. Wang, R. Salgia, and M. J. Ratain (2011)
Cancer Res.
71, 2423-2427
|Abstract »|Full Text »|PDF »
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy.
E. R. Cantwell-Dorris, J. J. O'Leary, and O. M. Sheils (2011)
Mol. Cancer Ther.
10, 385-394
|Abstract »|Full Text »|PDF »
Associations of Cumulative Sun Exposure and Phenotypic Characteristics with Histologic Solar Elastosis.
N. E. Thomas, A. Kricker, L. From, K. Busam, R. C. Millikan, M. E. Ritchey, B. K. Armstrong, J. Lee-Taylor, L. D. Marrett, H. Anton-Culver, et al. (2010)
Cancer Epidemiol. Biomarkers Prev.
19, 2932-2941
|Abstract »|Full Text »|PDF »
Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation.
A. L. Kadekaro, S. Leachman, R. J. Kavanagh, V. Swope, P. Cassidy, D. Supp, M. Sartor, S. Schwemberger, G. Babcock, K. Wakamatsu, et al. (2010)
FASEB J
24, 3850-3860
|Abstract »|Full Text »|PDF »
Population-based, Case-Control-Family Design to Investigate Genetic and Environmental Influences on Melanoma Risk: Australian Melanoma Family Study.
A. E. Cust, H. Schmid, J. A. Maskiell, J. Jetann, M. Ferguson, E. A. Holland, C. Agha-Hamilton, M. A. Jenkins, J. Kelly, R. F. Kefford, et al. (2009)
Am. J. Epidemiol.
170, 1541-1554
|Abstract »|Full Text »|PDF »
Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention.
A. G. Goodson, M. A. Cotter, P. Cassidy, M. Wade, S. R. Florell, T. Liu, K. M. Boucher, and D. Grossman (2009)
Clin. Cancer Res.
15, 7434-7440
|Abstract »|Full Text »|PDF »
Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R.
M. Muller, M. Obeyesekere, G. B. Mills, and P. T. Ram (2008)
FASEB J
22, 1393-1403
|Abstract »|Full Text »|PDF »
Is Sunlight Important to Melanoma Causation?.
M. A. Tucker (2008)
Cancer Epidemiol. Biomarkers Prev.
17, 467-468
|Full Text »|PDF »
UV or Not UV: Metals Are The Answer.
F. L. Meyskens Jr. and M. Berwick (2008)
Cancer Epidemiol. Biomarkers Prev.
17, 268-270
|Full Text »|PDF »
Survival for Patients With Invasive Cutaneous Melanoma Among Ethnic Groups: The Effects of Socioeconomic Status and Treatment.
J. A. Zell, P. Cinar, M. Mobasher, A. Ziogas, F. L. Meyskens Jr, and H. Anton-Culver (2008)
J. Clin. Oncol.
26, 66-75
|Abstract »|Full Text »|PDF »
Identification of prostate cancer modifier pathways using parental strain expression mapping.
Q. Xu, P. K. Majumder, K. Ross, Y. Shim, T. R. Golub, M. Loda, and W. R. Sellers (2007)
PNAS
104, 17771-17776
|Abstract »|Full Text »|PDF »
CanPredict: a computational tool for predicting cancer-associated missense mutations.
J. S. Kaminker, Y. Zhang, C. Watanabe, and Z. Zhang (2007)
Nucleic Acids Res.
35, W595-W598
|Abstract »|Full Text »|PDF »
Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma.
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al. (2007)
Cancer Epidemiol. Biomarkers Prev.
16, 991-997
|Abstract »|Full Text »|PDF »
Toward a Molecular Classification of Melanoma.
L. A. Fecher, S. D. Cummings, M. J. Keefe, and R. M. Alani (2007)
J. Clin. Oncol.
25, 1606-1620
|Abstract »|Full Text »|PDF »
Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms.
J. S. Kaminker, Y. Zhang, A. Waugh, P. M. Haverty, B. Peters, D. Sebisanovic, J. Stinson, W. F. Forrest, J. F. Bazan, S. Seshagiri, et al. (2007)
Cancer Res.
67, 465-473
|Abstract »|Full Text »|PDF »
Genetic Supervision of Melanoma by MC1R.
(2006)
Journal Watch Dermatology
2006, 2
|Full Text »